Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration

NCT02174848 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Pantothenate Kinase-Associated Neurodegeneration

Interventions

DRUG: Deferiprone oral solution

Sponsor

ApoPharma